The Association of Cord Serum Cytokines with Neurodevelopmental Outcomes

Abstract

Objective To test whether elevated umbilical cord serum inflammatory cytokine levels predicted subsequent cerebral palsy (CP) or neurodevelopmental delay (NDD).

Study Design Nested case-control analysis within a clinical trial of antenatal magnesium sulfate (MgSO₄) before anticipated preterm birth (PTB) for prevention of CP, with evaluation of surviving children at the age of 2. NDD was defined as a Bayley psychomotor developmental index (PDI) and/or mental developmental index (MDI) < 70. Controls, defined as surviving children without CP and with Bayley PDI and MDI ≥ 85, were matched by race and gestational age. Cord serum was analyzed for interleukin-8 (IL-8) interleukin-1 beta (IL-1β), and tumor necrosis factor-α (TNF-α) levels. Elevated cytokine levels were defined as ≥ 75th percentile in placebo-exposed controls. Analyses compared case/control cytokine levels, adjusting for MgSO₄ exposure, gestational age, race/ethnicity, and sociodemographic differences.

Results Logistic regression analysis with 339 cases and 276 controls showed that elevated IL-8 and IL-1β were more common in cord blood serum from infants with subsequent low MDI as compared with controls. After adjusting for additional confounders, the significant differences were no longer evident. Cytokine levels (IL-8, IL-1β, and TNF-α) were not elevated with CP or low PDI.

Conclusion Cord serum IL-8, IL-1β, and TNF-α levels in preterm infants are not associated with subsequent CP or NDD.

Keywords

cytokines - cerebral palsy - neurodevelopmental outcomes - prematurity - magnesium sulfate

Notes

Comments and views of the authors do not necessarily represent views of the NICHD or NINDS. (ClinicalTrials.gov number, NCT00014989.) Presented in part at the 30th annual meeting of the Society for Maternal-Fetal Medicine, Chicago, IL, February 4, 2010.

• References

• 1 Bax M, Goldstein M, Rosenbaum P , et al; Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005; 47 (8) 571-576
• 2 Shatrov JG, Birch SC, Lam LT, Quinlivan JA, McIntyre S, Mendz GL. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 2010; 116 (2 Pt 1) 387-392
• 3 Bale Jr JF. Fetal infections and brain development. Clin Perinatol 2009; 36 (3) 639-653
• 4 Costantine MM, How HY, Coppage K, Maxwell RA, Sibai BM. Does peripartum infection increase the incidence of cerebral palsy in extremely low birthweight infants?. Am J Obstet Gynecol 2007; 196 (5) e6-e8
• 5 Silverstein FS, Barks JDE, Hagan P, Liu XH, Ivacko J, Szaflarski J. Cytokines and perinatal brain injury. Neurochem Int 1997; 30 (4-5) 375-383
• 6 Silveira RC, Procianoy RS. Interleukin-6 and tumor necrosis factor-α levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003; 143 (5) 625-629
• 7 Yoon BH, Jun JK, Romero R , et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177 (1) 19-26
• 8 Oygür N, Sönmez O, Saka O, Yeğin O. Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-α and interleukin-1 β concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998; 79 (3) F190-F193
• 9 Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1β, IL-6 and TNF-α and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006; 28 (3) 178-182
• 10 Chiesa C, Pellegrini G, Panero A , et al. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003; 33 (4) 352-358
• 11 Weeks JW, Reynolds L, Taylor D, Lewis J, Wan T, Gall SA. Umbilical cord blood interleukin-6 levels and neonatal morbidity. Obstet Gynecol 1997; 90 (5) 815-818
• 12 Andrews WW, Cliver SP, Biasini F , et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol 2008; 198 (4) e1-e11
• 13 Nelson KB, Grether JK, Dambrosia JM , et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003; 53 (4) 600-607
• 14 Rouse DJ, Hirtz DG, Thom E , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (9) 895-905
• 15 Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39 (4) 214-223
• 16 Bayley N. Bayley Scores of Infant Development. 2nd ed. New York, NY: Psychological Corporation; 1993
• 17 Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25 (1) 21-39
• 18 Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342 (20) 1500-1507
• 19 Grether JK, Nelson KB, Walsh E, Willoughby RE, Redline RW. Intrauterine exposure to infection and risk of cerebral palsy in very preterm infants. Arch Pediatr Adolesc Med 2003; 157 (1) 26-32
• 20 Nelson KB. The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002; 8 (3) 146-150
• 21 Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003; 290 (20) 2677-2684
• 22 Matoba N, Yu Y, Mestan K , et al. Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics 2009; 123 (5) 1320-1328
• 23 Hansen-Pupp I, Hallin A-L, Hellström-Westas L , et al. Inflammation at birth is associated with subnormal development in very preterm infants. Pediatr Res 2008; 64 (2) 183-188